Insider trade

Director sold ~$198K of EXEL shares in the open market

Traded Jun 1, 2026 · Filed Jun 3, 2026

Why it stands out

A board member of Exelixis sold $198K of Exelixis shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$198,409

Shares × reported transaction price

Timing vs results

27 days after results of May 5, 2026, 65 days before results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.9%	−2.5%	+4.5%
30 days	+5.8%	−0.8%	+6.6%
90 days	+11.5%	+1.1%	+10.4%

Past results only. Not a forecast.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
Includes 8,367 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Scheduled in advance4mo ago

4mo ago

Compensation award — excluded from discretionary-purchase analysis.

4mo ago

Compensation award — excluded from discretionary-purchase analysis.